These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17602901)

  • 1. Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients.
    Huang HC; Liu CH; Lan TH; Hu TM; Chiu HJ; Wu YC; Tseng YL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):57-61. PubMed ID: 17602901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophrenia.
    Bachmann CJ; Rieger-Gies A; Heinzel-Gutenbrunner M; Hiemke C; Remschmidt H; Theisen FM
    Ther Drug Monit; 2008 Aug; 30(4):462-6. PubMed ID: 18641558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies.
    Akamine Y; Yasui-Furukori N; Kojima M; Inoue Y; Uno T
    J Sep Sci; 2010 Nov; 33(21):3292-8. PubMed ID: 21049519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of aripiprazole and its active metabolite, dehydroaripiprazole, in plasma by capillary electrophoresis combining on-column field-amplified sample injection and application in schizophrenia.
    Hwang PL; Wei SY; Yeh HH; Ko JY; Chang CC; Chen SH
    Electrophoresis; 2010 Aug; 31(16):2778-86. PubMed ID: 20665528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quantitative detection of aripiprazole and its main metabolite by using capillary-electrophoresis.
    Tsai CJ; Yu YH; Chiu HJ; Loh el-W; Wang JT; Chan CH; Lan TH
    J Chin Med Assoc; 2011 Jun; 74(6):267-71. PubMed ID: 21621170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved simple LC-MS/MS method for the measurement of serum aripiprazole and its major metabolite.
    Caloro M; Lionetto L; Cuomo I; Simonetti A; Pucci D; De Persis S; Casolla B; Kotzalidis GD; Sciarretta A; De Filippis S; Simmaco M; Girardi P
    J Pharm Biomed Anal; 2012 Mar; 62():135-9. PubMed ID: 22300908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.
    Suzuki T; Mihara K; Nakamura A; Nagai G; Kagawa S; Nemoto K; Ohta I; Arakaki H; Uno T; Kondo T
    Ther Drug Monit; 2011 Feb; 33(1):21-4. PubMed ID: 21157400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an LC-MS/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human plasma.
    Song M; Xu X; Hang T; Wen A; Yang L
    Anal Biochem; 2009 Feb; 385(2):270-7. PubMed ID: 19070586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects.
    Kirschbaum KM; Müller MJ; Malevani J; Mobascher A; Burchardt C; Piel M; Hiemke C
    World J Biol Psychiatry; 2008; 9(3):212-8. PubMed ID: 17853280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of comedication on serum concentrations of aripiprazole and dehydroaripiprazole.
    Waade RB; Christensen H; Rudberg I; Refsum H; Hermann M
    Ther Drug Monit; 2009 Apr; 31(2):233-8. PubMed ID: 19142178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic variability of aripiprazole and the active metabolite dehydroaripiprazole in psychiatric patients.
    Molden E; Lunde H; Lunder N; Refsum H
    Ther Drug Monit; 2006 Dec; 28(6):744-9. PubMed ID: 17164689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia.
    Nagai G; Mihara K; Nakamura A; Suzuki T; Nemoto K; Kagawa S; Ohta I; Arakaki H; Kondo T
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):518-24. PubMed ID: 23066770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of genetic polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia.
    Suzuki T; Mihara K; Nakamura A; Kagawa S; Nagai G; Nemoto K; Kondo T
    Ther Drug Monit; 2014 Oct; 36(5):651-5. PubMed ID: 24682161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of aripiprazole in rat plasma and brain using ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Liang F; Terry AV; Bartlett MG
    Biomed Chromatogr; 2012 Nov; 26(11):1325-32. PubMed ID: 22259043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a high-performance liquid chromatography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human plasma.
    Lancelin F; Djebrani K; Tabaouti K; Kraoul L; Brovedani S; Paubel P; Piketty ML
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):15-9. PubMed ID: 18356121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma.
    Kubo M; Mizooku Y; Hirao Y; Osumi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):294-9. PubMed ID: 16005688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of aripiprazole and concomitant carbamazepine.
    Citrome L; Macher JP; Salazar DE; Mallikaarjun S; Boulton DW
    J Clin Psychopharmacol; 2007 Jun; 27(3):279-83. PubMed ID: 17502775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an LC-ESI-MS method for quantitative determination of aripiprazole in human plasma and an application to pharmacokinetic study.
    Ravinder S; Bapuji AT; Mukkanti K; Raju DR; Ravikiran HL; Reddy DC
    J Chromatogr Sci; 2012; 50(10):893-901. PubMed ID: 22767645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-performance liquid chromatography method using ultraviolet detection for the quantification of aripiprazole and dehydroaripiprazole in psychiatric patients.
    Dorado P; de Andrés F; Naranjo ME; Peñas-Lledó EM; González I; González AP; de la Rubia A; Llerena A
    Drug Metabol Drug Interact; 2012; 27(3):165-70. PubMed ID: 23089607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of HPLC-UV method for aripiprazole determination in serum].
    Synowiec A; Gomółka E; Zyss T; Zieba A; Florek E; Piekoszewski W
    Przegl Lek; 2012; 69(10):1004-6. PubMed ID: 23421079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.